EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The role of gut microbiota in breast cancer: biomarker identification and therapeutic applications

Melika Abrishami, Mohadeseh Sabouri, Fereshte Joneidi, Zahra Haghshenas, Ghazaleh Khalili-Tanha, Elham Nazari

Antonie van Leeuwenhoek · 2026

DOI: 10.1007/s10482-025-02217-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antonie van Leeuwenhoek, 2026. Verfasst von Melika Abrishami und 5 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Medical Laboratory Sciences Department, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences…. Hauptthemen laut MEDLINE: Breast Neoplasms, Gastrointestinal Microbiome, Biomarkers, Tumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 118 Literaturangaben. Gefördert von: Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent studies have established the gut microbiome as a crucial player in breast cancer diagnosis, progression, and treatment. Distinct microbial patterns have shown promise as non-invasive diagnostic and prognostic biomarkers, supporting patient stratification and risk assessment based on microbiota composition. The gut microbiome also modulates estrogen metabolism, influencing the risk of hormone receptor-positive breast cancer, while dysbiosis can promote chronic inflammation and tumor expansion. Moreover, accumulating evidence demonstrates that gut bacteria can alter responses to chemotherapy and immunotherapy, suggesting that microbiota modulation may enhance treatment efficacy. With the advent of omics technologies and machine learning, intricate host-microbe interactions are being decoded, revealing new molecular targets and therapeutic opportunities. Importantly, early clinical and interventional studies using probiotics, prebiotics, and fecal microbiota transplantation (FMT) are being explored to restore microbial balance, mitigate therapy-related side effects, and improve antitumor immunity in breast cancer patients. Together, these advances underscore the translational potential of microbiome research, paving the way for microbiota-guided diagnostic, prognostic, and therapeutic strategies in personalized breast cancer management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsGastrointestinal MicrobiomeBiomarkers, TumorHumansFemaleDysbiosisProbioticsFecal Microbiota Transplantation

Stichwörter der Autor:innen

BiomarkerBreast cancerGut microbiotaProbioticsTherapeutic

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Student Research Committee, Medical Laboratory Sciences Department, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Pharmaceutical Biotechnology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Ghazaleh.Khalili24@gmail.com.
  • Department of Medical Genetics and Molecular Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Ghazaleh.Khalili24@gmail.com.
  • Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. elham.nazari@sbmu.ac.ir.

Förderung

  • Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Zitieren

APA

Abrishami, M., Sabouri, M., Joneidi, F., Haghshenas, Z., Khalili-Tanha, G., & Nazari, E. (2026). The role of gut microbiota in breast cancer: biomarker identification and therapeutic applications. Antonie van Leeuwenhoek. https://doi.org/10.1007/s10482-025-02217-2

Vancouver

Abrishami M, Sabouri M, Joneidi F, Haghshenas Z, Khalili-Tanha G, Nazari E. The role of gut microbiota in breast cancer: biomarker identification and therapeutic applications. Antonie van Leeuwenhoek. 2026. doi:10.1007/s10482-025-02217-2

BibTeX
@article{Abrishami2026,
  author = {Abrishami, Melika and Sabouri, Mohadeseh and Joneidi, Fereshte and Haghshenas, Zahra and Khalili-Tanha, Ghazaleh and Nazari, Elham},
  title = {The role of gut microbiota in breast cancer: biomarker identification and therapeutic applications},
  journal = {Antonie van Leeuwenhoek},
  year = {2026},
  doi = {10.1007/s10482-025-02217-2}
}
Kostenlos starten →